Attached files

file filename
8-K - FORM 8-K - ARENA PHARMACEUTICALS INCd281305d8k.htm
EX-4.6 - FORM OF CERTIFICATE OF DESIGNATIONS OF SERIES D CONVERTIBLE PREFERRED STOCK - ARENA PHARMACEUTICALS INCd281305dex46.htm
EX-4.5 - FORM OF SPECIMEN PREFERRED STOCK CERTIFICATE - ARENA PHARMACEUTICALS INCd281305dex45.htm
EX-5.1 - OPINION OF ARENA'S GENERAL COUNSEL - ARENA PHARMACEUTICALS INCd281305dex51.htm
EX-99.5 - PRESS RELEASE - ARENA PHARMACEUTICALS INCd281305dex995.htm
EX-99.3 - EXCHANGE AGREEMENT - ARENA PHARMACEUTICALS INCd281305dex993.htm
EX-99.1 - SECURITIES PURCHASE AGREEMENT - ARENA PHARMACEUTICALS INCd281305dex991.htm
EX-99.4 - FORM OF WARRANT TO PURCHASE COMMON STOCK OF ARENA - ARENA PHARMACEUTICALS INCd281305dex994.htm

Exhibit 99.2

THIRD AMENDMENT TO FACILITY AGREEMENT

THIRD AMENDMENT dated as of January 10 2012 (this “Amendment”) to the FACILITY AGREEMENT (the “Agreement”), dated as of June 17, 2009, as amended on August 5, 2010 and March 28, 2011, between Arena Pharmaceuticals, Inc., a Delaware corporation (the “Borrower”), and those lenders set forth on the signature page hereof (individually, a “Lender” and together, the “Lenders” and, collectively with the Borrower, the “Parties”).

WITNESSETH:

WHEREAS, on July 6, 2009, the Borrower borrowed from the Lenders $100,000,000 pursuant to the Agreement;

WHEREAS, on the date hereof the Borrower and the Lenders have entered into a Securities Purchase Agreement (the “SPA-2012”), pursuant to which the Lenders have agreed to purchase from the Borrower, and the Borrower has agreed to issue and sell to the Lenders, shares of the Borrower’s Common Stock and Preferred Stock; and

WHEREAS, the Borrower desires to prepay the Loan (as defined in the Agreement) in the aggregate amount of $5,000,000;

NOW, THEREFORE, in consideration of the mutual agreements set forth herein, the Lenders and the Borrower agree as follows:

1. Concurrently with the Closing (as defined in the SPA) the Borrower shall prepay the Loan in the amount of $5,000,000. Section 2.12(d) of the Agreement shall not apply to such prepayment.

2. Section 1.1 of the Agreement is amended to add a definition entitled “SPA-2012” to read as follows:

SPA-2012” means that certain Securities Purchase Agreement, dated as of January 10, 2012, by and between Borrower and the Lenders.”

3. Section 5.2 of the Agreement is amended to add thereto a subsection (f) to read as follows:

“(f) The Borrower shall not, during the 30 day period following the closing of the SPA-2012, sell any Common Stock, Convertible Securities or options, other than in an Exempted Issuance.”

4. Except as amended by this Amendment, the Agreement remains in full force and effect.


IN WITNESS WHEREOF, the undersigned Lenders and the Borrower have caused this Amendment to be duly executed as of the date first written above.

 

BORROWER:     LENDERS:

ARENA PHARMACEUTICALS, INC.

    DEERFIELD PRIVATE DESIGN FUND, L.P.

By:

 

/s/ Robert E. Hoffman

    By:   Deerfield Capital, L.P., its General Partner

Name:

 

Robert E. Hoffman

     

Title:

 

Vice President, Finance and

Chief Financial Officer

   

By:

  J.E. Flynn Capital LLC, its General Partner
      By:  

/s/ David J. Clark

      Name:   David J. Clark
      Its:   Authorized Signatory
     

DEERFIELD PRIVATE DESIGN

INTERNATIONAL, L.P.

      By:   Deerfield Capital, L.P., its General Partner
      By:   J.E. Flynn Capital LLC, its General Partner
      By:  

/s/ David J. Clark

      Name:   David J. Clark
      Its:   Authorized Signatory
      DEERFIELD PARTNERS, L.P.
      By:   Deerfield Capital, L.P., its General Partner
      By:   J.E. Flynn Capital LLC, its General Partner
      By:  

/s/ David J. Clark

      Name:   David J. Clark
      Its:   Authorized Signatory
      DEERFIELD INTERNATIONAL LIMITED
      By:  

/s/ David J. Clark

      Name:   David J. Clark
      Its:   Authorized Signatory

 

2


DEERFIELD SPECIAL SITUATIONS FUND, L.P.
By:   Deerfield Capital, L.P., its General Partner
By:   J.E. Flynn Capital LLC, its General Partner
By:  

/s/ David J. Clark

Name:   David J. Clark
Its:   Authorized Signatory

DEERFIELD SPECIAL SITUATIONS

FUND INTERNATIONAL LIMITED

By:  

/s/ David J. Clark

Name:   David J. Clark
Its:   Authorized Signatory

 

3